A Phase I Trial of Farnesyltransferase Inhibitor, R115777 (NSC # 702818) and Radiotherapy in Patients With Non-Small Cell Lung Cancer
Phase of Trial: Phase I
Latest Information Update: 13 Oct 2009
At a glance
- Drugs Tipifarnib (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 13 Oct 2009 Additional lead trial centre (Abramson Cancer Center of the University of Pennsylvania) investigator (Hahn SM) identified as reported by ClinicalTrials.gov.
- 04 Jun 2007 Status changed from in progress to completed.
- 08 May 2007 Status changed from recruiting to in progress.